JohnWGnannJr.MD

PubMed

• 8 citations
  Risk Factors for Mortality and Progression to Severe COVID-19 Disease in the Southeast United States (US): A Report from the SEUS Study Group.
  Athena L V Hobbs, Nicholas A Turner, Imad Omer, Morgan Walker, Ronald M Beaulieu, Muhammad Sheikh, Steven S Spires, Christina T. Fiske, Ryan K Dare, Salil Goorha, Priy...> ;Infection Control and Hospital Epidemiology. 2021 Jan 11
• 28 citations
  Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease.
  John W. Gnann, Amy Guillet Agrawal, John Hart, Martha I. Buitrago, Paul J. Carson, Diane Hanfelt-Goade, Kenneth L. Tyler, Jared Spotkov, Alison G. Freifeld, Thomas C. ...> ;Emerging Infectious Diseases. 2019 Nov 1
• 2 citations
  Histoplasma meets Crohn’s disease: a rare case of new-onset ascites
  Charles Bosshardt, John W. Gnann, Nilesh Lodhia> ;BMJ Case Reports. 2018 Apr 17
• 94 citations
  Herpes Simplex Encephalitis: An Update
  John W. Gnann, Richard J. Whitley> ;Current Infectious Disease Reports. 2017 Mar 1
• Genital Herpes.
  Gnann, J. W., Whitley, R. J.> ;The New England journal of medicine. 2016 Dec 14
• 34 citations
  CLINICAL PRACTICE. Genital Herpes.
  John W. Gnann, Richard J. Whitley> ;The New England Journal of Medicine. 2016 Aug 18
• 24 citations
  Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia.
  Shawn H. MacVane, John M. Hurst, M. Sean Boger, John W. Gnann> ;Infectious Diseases. 2016 May 19
• 3 citations
  Gnann JW et al (Clin Infect Dis 2015; 61:683-91). Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy
  John W. Gnann, Birgit Sköldenberg, John Hart> ;Clinical Infectious Diseases. 2015 Nov 4
• 11 citations
  Disseminated Herpes Simplex Virus with Fulminant Hepatitis.
  Bassam H. Rimawi, Joseph Meserve, Ramzy H. Rimawi, Zaw Min, John W. Gnann> ;Case Reports in Hepatology. 2015 Jul 28
• 49 citations
  Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy
  John W. Gnann, Birgit Sköldenberg, John Hart, Elisabeth Aurelius, Silvia Schliamser, Marie Studahl, Britt Marie Eriksson, Daniel F. Hanley, Fred Y. Aoki, Alan Jackson,...> ;Clinical Infectious Diseases. 2015 Sep 1
• 78 citations
  West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes
  John Hart, Gail D. Tillman, Michael A. Kraut, Hsueh Sheng Chiang, Jeremy F. Strain, Yufeng Li, Amy Guillet Agrawal, Penny Jester, John W. Gnann, Richard J. Whitley> ;BMC Infectious Diseases. 2014 May 9
• 2 citations
  Mosquito bites and eastern equine encephalitis
  Zaw Min, John W. Gnann> ;QJM. 2014 May 1
• 2 citations
  Kaposi’s varicelliform eruption
  Zaw Min, John W. Gnann> ;Internal and Emergency Medicine. 2014 Feb 1
• 29 citations
  Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine
  Myron J. Levin, Kenneth E. Schmader, John W. Gnann, Shelly A. McNeil, Timo Vesikari, Robert F. Betts, Susan Keay, Jon E. Stek, Nickoya D. Bundick, Shu-Chih Su, Yanli Z...> ;The Journal of Infectious Diseases. 2013 Nov 1
• 6 citations
  Reversible posterior leukoencephalopathy syndrome
  Zaw Min, John W. Gnann> ;Internal and Emergency Medicine. 2014 Apr 1
• 30 citations
  Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster
  Vicki A. Morrison, Michael N. Oxman, Myron J. Levin, Kenneth E. Schmader, John C. Guatelli, Robert F. Betts, Larry D. Gelb, Constance T. Pachucki, Susan Keay, Barbara ...> ;The Journal of Infectious Diseases. 2013 Aug 15
• 7 citations
  Varicella-zoster virus: Prevention through vaccination.
  John W. Gnann> ;Clinical Obstetrics and Gynecology. 2012 Jun 1
• 311 citations
  Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years
  Kenneth E. Schmader, Myron J. Levin, John W. Gnann, Shelly A. McNeil, Timo Vesikari, Robert F. Betts, Susan Keay, Jon E. Stek, Nickoya D. Bundick, Shu-Chih Su, Yanli Z...> ;Clinical Infectious Diseases. 2012 Apr 1
• 54 citations
  Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor-α Inhibitors
  Russell D. Bradford, April C. Pettit, Patty W. Wright, Mark J. Mulligan, Larry W. Moreland, David A. McLain, John W. Gnann, Karen C. Bloch> ;Clinical Infectious Diseases. 2009 Sep 15
• 22 citations
  Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients.
  S. Baer, John W. Baddley, John W. Gnann, Peter G. Pappas> ;Transplant Infectious Disease. 2009 Aug 1
• 61 citations
  A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.
  Robert H. Dworkin, Richard L. Barbano, Stephen K. Tyring, Robert F. Betts, Michael P. McDermott, Janet Pennella-Vaughan, Gary J. Bennett, Erhan Berber, John W. Gnann, ...> ;Pain. 2009 Apr 1
• 18 citations
  Herpes Zoster in the Age of Focused Immunosuppressive Therapy
  Richard J. Whitley, John W. Gnann> ;JAMA. 2009 Feb 18
• 12 citations
  Famciclovir Treatment Options for Patients With Frequent Outbreaks of Recurrent Genital Herpes: The RELIEF Trial
  Brenda L. Bartlett, Stephen K. Tyring, Kenneth H. Fife, John W. Gnann, Joseph T. Hadala, Farid Kianifard, Erhan Berber> ;Journal of Clinical Virology. 2008 Oct 1
• 106 citations
  The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine
  Kenneth E. Schmader, John W. Gnann, C. Peter N. Watson> ;The Journal of Infectious Diseases. 2008 Mar 1
• 23 citations
  Vaccination to Prevent Herpes Zoster in Older Adults
  John W. Gnann> ;The Journal of Pain. 2008 Jan 1
• Join now to see all

Journal Articles

• Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from Centers for Disease Control and Pr...  
  Kaplan, J.E., C. Benson, K.H. Holmes, J.T. Brooks, A. Pau, H. Masur (eds.), Centers for Disease Control and Prevention, National Institutes of Health, and the HIV Medi..., Morbid Mortal Weekly Report, 1/1/2013
• Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality- of-life measures in older adults  
  Schmader KE, Johnson GR, Saddier P, Ciarleglio M, Wang WW, Zhang JH, Chan IS, Yeh SS, Levin MJ, Harbecke RM, Oxman MN, Shingles Prevention Study Group, J. Am. Geriatr. Soc., 1/1/2010
• Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine  
  Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD,..., J Infect Dis., 1/1/2009
• Herpes zoster in the age of focused immunosuppressive therapy (editorial)  
  Whitley, R.J., J.W. Gnann., J. Am. Med. Assoc., 1/1/2009
• Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients  
  Baer, S., J.W. Baddley, J.W. Gnann, P.G. Pappas., Transpl. Infect. Dis., 1/1/2009
• A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and co...  
  Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberko..., J. Med. Virol., 1/1/2009
• Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from Centers for Disease Control and Pr...  
  Kaplan, J.E., C. Benson, K.H. Holmes, J.T. Brooks, A. Pau, H. Masur, Centers for Disease Control and Prevention, National Institutes of Health, and the HIV Medicine As..., Morbid Mortal Weekly Report, 1/1/2009
• Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors  
  Bradford, R.D., A.C. Pettit, P.W. Wright, M.J. Mulligan, L.W. Moreland, D.A. McLain, J.W. Gnann, K.C. Bloch., Clin. Infect. Dis., 1/1/2009
• Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia  
  Dworkin, R.H., J.W. Gnann, A.L. Oaklander, S. Raja, K.E. Schmader, R.J. Whitley., J. Pain, 1/1/2008
• Vaccination to prevent herpes zoster in older adults  
  Gnann, J.W., J. Pain, 1/1/2008
• Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial  
  B.L. Bartlett, S. Tyring, K. Fife, J.W. Gnann, J.T. Hadala, F. Kianifard, E. Berber., J Clin Virol, 1/1/2008
• Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine  
  Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Ger..., J Infect Dis., 1/1/2008
• The epidemiological, clinical, and pathological rationale for the zoster vaccine  
  Schmader, K., J.W. Gnann, C.P. Watson., J. Infect. Dis., 1/1/2008
• Recommendations for the management of herpes zoster  
  Dworkin, R.H., R.W. Johnson, J. Breuer, J.W. Gnann, M.J. Levin, M. Backonja, R.F. Betts, A.A. Gershon, M.L. Haanpää, M.W. McKendrick, T.J. Nurmikko, A.L. Oaklander, M...., Clin. Infect. Dis., 1/1/2007
• Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant rec...  
  Boeckh, M., J. Englund, M. Carpenter, Y. Li, C. Miller, A. Cross, H. Fernandez, J. Kuypers, H. Kim, J. Gnann, and R. Whitley for the NIAID Collaborative Antiviral Stud..., Clin. Infec. Dis., 1/1/2007
• The incidence and severity of herpes simplex virus encephalitis in Sweden, 1990-2001 (editorial)  
  Whitley, R.J., J.W. Gnann., Clin. Infect. Dis., 1/1/2007
• Current antiviral treatments for varicella  
  Gnann, J.W., Herpes, 1/1/2006
• Antiviral therapy for herpes zoster  
  Gnann, J.W., Herpes, 1/1/2006
• A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults  
  Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzz..., N. Engl. J. Med., 1/1/2005
• A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients  
  Davis, G.L., D.R. Nelson, N. Terrault, T.L. Pruett, T.D. Schiano, C.V. Fletcher, C.V. Sapan, L.N. Riser, Y. Li, R.J. Whitley, J.W. Gnann, and the NIAID Collaborative A..., Liver Transplantation, 1/1/2005
• A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-cytomegalovirus antibody (MSL-109) in combination with standard therapy...  
  Borucki, M.J., J. Spritzler, D.M. Asmuth, J. Gnann, M.S. Hirsch, M. Nokta, F. Aweeka, P.I. Nadler, F. Sattler, B. Alston, T.T. Nevin, S. Owens, K. Waterman, L. Hubbard..., Antiviral Research, 1/1/2004
• The safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza  
  Ison, M.G., J.W. Gnann, S. Nagy-Agren, J. Treanor, C. Paya, R. Steigbigel, M. Elliott, H.L. Weiss, and F.G. Hayden for the NIAID Collaborative Antiviral Study Group, Antiviral Therapy, 1/1/2003
• A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell cou...  
  Wright, P.W., C.J. Hoesley, K.E. Squires, A. Croom-Rivers, H.L. Weiss, and J.W. Gnann, Jr., Clin. Infec. Dis., 1/1/2003
• Herpes zoster (letter)  
  Gnann, J.W. and R.J. Whitley., N. Engl. J. Med., 1/1/2003
• Clinical applications for change-point analysis of herpes zoster pain  
  Desmond, R.A., H.L. Weiss, R.B. Arani, S. Soong, M.J. Wood, P.A. Fiddian, J.W. Gnann, and R.J. Whitley., J. Pain Symptom Manage, 1/1/2002
• Join now to see all